Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis

Pediatric Infectious Disease Journal

Volumn 31, Issue 9, 2012, Pages 992-994

  Hemming, Maria ^a   Vesikari, Timo ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

diarrhea; RotaTeq; rotavirus vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CASE REPORT; DEHYDRATION; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; NEWBORN; OUTCOME ASSESSMENT; PALLOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VOMITING;

ACUTE DISEASE; FECES; FEMALE; GASTROENTERITIS; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; REASSORTANT VIRUSES; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 84865489159     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31825d611e     Document Type: Article

References (22)

1. Vesikari T, Matson DO, Dennehy P, et al. Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
2. Heaton PM, Ciarlet M. Vaccines: the pentavalent rotavirus vaccine: discov-ery to licensure and beyond. Clin Infect Dis. 2007;45:1618-1624.
3. Ciarlet M, Schödel F. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq. Vaccine. 2009;27(suppl 6):G72-G81.
4. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavi-rus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199-e207.
5. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J. 2011;30(suppl 1):S56-S60.
6. Glass RI. Unexpected benefits of rotavirus vaccination in the United States. J Infect Dis. 2011;204:975-977.
7. Patel NC, Hertel PM, Estes MK, et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med. 2010;362:314-319.
8. Payne DC, Edwards KM, Bowen MD, et al. Sibling transmission of vaccine derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pedi-atrics. 2010;125:e438-e441.
9. Räsänen S, Lappalainen S, Halkosalo A, et al. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination. Scand J Infect Dis. 2011;43:58-63.
10. Iturriza Gómara M, Wong C, Blome S, et al. Rotavirus subgroup characteri-sation by restriction endonuclease digestion of a cDNA fragment of the VP6 gene. J Virol Methods. 2002;105:99-103.
11. Blazevic V, Lappalainen S, Nurminen K, et al. Norovirus VLPs and rotavi-rus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine. 2011;29:8126-8133.
12. Puustinen L, Blazevic V, Salminen M, et al. Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010. Scand J Infect Dis. 2011;43:804-808.
13. Risku M, Lappalainen S, Räsänen S, et al. Detection of human coronavi-ruses in children with acute gastroenteritis. J Clin Virol. 2010;48:27-30.
14. Gray J, Vesikari T, Van Damme P, et al. Rotavirus. J Pediatr Gastroenterol Nutr. 2008;46(suppl 2):S24-S31.
15. Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect. 2001;3:1145-1156.
16. Clark HF, Bernstein DI, Dennehy PH, et al. Safety, efficacy, and immuno-genicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr. 2004;144:184-190.
17. Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8:642-649.
18. Chan J, Nirwati H, Triasih R, et al. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine. 2011;29:1242-1247.
19. Clark HF, Marcello AE, Lawley D, et al. Unexpectedly high burden of rota-virus gastroenteritis in very young infants. BMC Pediatr. 2010;10:40.
20. Yen C, Jakob K, Esona MD, et al. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine. 2011;29:4151-4155.
21. Smith CK, McNeal MM, Meyer NR, et al. Rotavirus shedding in premature infants following first immunization. Vaccine. 2011;29:8141-8146.
22. Vesikari T, Clark HF, Offit PA, et al. Effects of the potency and compo-sition of the multivalent human-bovine (WC3) reassortant rotavirus vac-cine on efficacy, safety and immunogenicity in healthy infants. Vaccine. 2006;24:4821-4829.